Point72 Asset Management
ONC

Point72 Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Point72 Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-223,443
Closed -$60.8M – 2674
2025
Q1 		$60.8M Buy
223,443
+198,277
+788% +$46.4M 0.14% 183
2024
Q4 		$4.65M Sell
25,166
-642,000
-96% -$131M 0.01% 972
2024
Q3 		$150M Buy
667,166
+285,784
+75% +$51.4M 0.38% 34
2024
Q2 		$54.4M Buy
+381,382
New +$58.8M 0.14% 199

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management's ONC Position: Q2 2025 in Review

Point72 Asset Management sold out of BeOne Medicines Ltd (ONC) in Q2 2025, closing a stake of 223,443 shares — an estimated $60.8M sold.

Point72 Asset Management first reported a position in ONC in Q2 2024 and held it in 4 quarters. The position peaked at $150M in Q3 2024. 244 funds tracked by Wall St. Rank hold ONC as of Q2 2025.

  • Point72 Asset Management reported no remaining BeOne Medicines Ltd position as of Q2 2025 after selling out during the quarter.
  • Point72 Asset Management sold 223,443 BeOne Medicines Ltd shares in Q2 2025, an estimated $60.8M.
  • Point72 Asset Management first reported a position in BeOne Medicines Ltd in Q2 2024 and held it in 4 quarters.
  • Point72 Asset Management's BeOne Medicines Ltd position peaked at $150M in Q3 2024.
  • 244 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2025.

Based on Point72 Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.